TP53 and neoplasm: To determine the impact of mutant Trp53R172H on St6galnac‐I expression in LUAD, we ectopically expressed the mutant Trp53R172H in the KA tumor syngeneic cell line (KA1418 has wild‐type Trp53 derived from KrasG12D‐activated tumor).